Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease

This publication has 26 references indexed in Scilit:

• PRO18 A Systematic Literature Review of the Economic Burden and Cost Drivers in Pulmonary Arterial Hypertension
  Value in Health, 2021
• Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
  New England Journal of Medicine, 2021
• The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease
  Chest, 2020
• Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography
  Journal of the American Society of Echocardiography, 2019
• PVDOMICS
  Circulation Research, 2017
• Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation
  The Annals of Thoracic Surgery, 2016
• Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
  New England Journal of Medicine, 2014
• A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
  New England Journal of Medicine, 2014
• Geometry of the Randomized Evidence for Treatments of Pulmonary Hypertension
  Cardiovascular Therapeutics, 2013
• Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
  BMJ, 2007